- Home
- Publications
- Publication Search
- Publication Details
Title
GIP(3-30)NH2 – a tool for the study of GIP physiology
Authors
Keywords
-
Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 55, Issue -, Pages 31-40
Publisher
Elsevier BV
Online
2020-10-12
DOI
10.1016/j.coph.2020.08.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals
- (2020) Lærke S Gasbjerg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Editorial: GIP renaissance
- (2020) Peter R. Flatt et al. PEPTIDES
- Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
- (2020) Aimo Kannt et al. DIABETES OBESITY & METABOLISM
- 89-LB: The Effect of GIP on Plasma Glucose in a Setting of Prandial Insulin Overdose and Physical Activity after Meal Intake in Patients with Type 1 Diabetes
- (2020) BJØRN HOE et al. DIABETES
- Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
- (2020) Francis S. Willard et al. JCI Insight
- Separate and Combined Gluco-Metabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 in Healthy Individuals
- (2019) Lærke S. Gasbjerg et al. DIABETES
- GIP and GLP-1: Stepsiblings Rather Than Monozygotic Twins Within the Incretin Family
- (2019) Michael A. Nauck et al. DIABETES
- 64-OR: Postprandial Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide in Type 2 Diabetes
- (2019) SIGNE STENSEN et al. DIABETES
- GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men
- (2019) Kirsa Skov-Jeppesen et al. BONE
- Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
- (2019) Sara Baldassano et al. Frontiers in Endocrinology
- Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
- (2019) Marie Bastin et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists
- (2019) Lærke S. Gasbjerg et al. PEPTIDES
- GIP and the gut-bone axis – Physiological, pathophysiological and potential therapeutic implications
- (2019) Signe Stensen et al. PEPTIDES
- GIP’s effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3–30)NH2
- (2019) Lærke S. Gasbjerg et al. BONE
- Cardiovascular biology of the GIP receptor
- (2019) Amanda A. Greenwell et al. PEPTIDES
- Molecular interactions of full-length and truncated GIP peptides with the GIP receptor – A comprehensive review
- (2019) Maria Buur Nordskov Gabe et al. PEPTIDES
- Recent advances of GIP and future horizons
- (2019) Jens Juul Holst et al. PEPTIDES
- Human GIP(3-30)NH 2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors
- (2018) Maria Buur Nordskov Gabe et al. BIOCHEMICAL PHARMACOLOGY
- Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction
- (2018) John R. Ussher et al. Cell Metabolism
- Structure of the glucagon receptor in complex with a glucagon analogue
- (2018) Haonan Zhang et al. NATURE
- Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
- (2018) Christoffer Clemmensen et al. Nature Reviews Endocrinology
- Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
- (2017) Gaojie Song et al. NATURE
- Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects
- (2017) Tsuyoshi Yanagimachi et al. Molecular Metabolism
- N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor
- (2016) L S Hansen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reappraisal of GIP Pharmacology for Metabolic Diseases
- (2016) Brian Finan et al. TRENDS IN MOLECULAR MEDICINE
- Alternative form of glucose-dependent insulinotropic polypepide and its physiology
- (2016) Yukihiro Fujita et al. Journal of Diabetes Investigation
- Searching for the physiological role of glucose-dependent insulinotropic polypeptide
- (2016) Jens Juul Holst et al. Journal of Diabetes Investigation
- The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
- (2016) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Selectivity of pharmacological tools: implications for use in cell physiology. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
- (2015) Martin C. Michel et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
- (2015) A H Sparre-Ulrich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evidence of Extrapancreatic Glucagon Secretion in Man
- (2015) Asger Lund et al. DIABETES
- Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice
- (2015) V. Pathak et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity
- (2014) S. Mohammad et al. MOLECULAR AND CELLULAR BIOLOGY
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality
- (2013) Aleksandra Mieczkowska et al. BONE
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
- (2011) M. Christensen et al. DIABETES
- Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation
- (2011) Su-Jin Kim et al. JOURNAL OF LIPID RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now